Key result
Pretreatment with unfractioned heparin alongside dual antiplatelet therapy is discussed as a potential standard of care in patients undergoing primary percutaneous coronary intervention.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fabris et al. (2023) studied this question. Pretreatment with unfractioned heparin alongside dual antiplatelet therapy is discussed as a potential standard of care in patients undergoing primary percutaneous coronary intervention.
Synapse has enriched 10 related papers. Consider them for comparative context: